Literature DB >> 23567660

Does the number of simultaneously activated electrodes during phased RF multielectrode ablation of atrial fibrillation influence the incidence of silent cerebral microembolism?

Marcus Wieczorek1, Reinhard Hoeltgen, Martin Brueck.   

Abstract

BACKGROUND: Asymptomatic cerebral embolus (ACE) detected by diffusion-weighted magnetic resonance imaging (DW-MRI) following atrial fibrillation (AF) ablation has been reported at varying rates with different ablation techniques.
OBJECTIVE: To evaluate the incidence of ACE after phased radiofrequency ablation for AF with procedural modifications that potentially reduce the embolic load.
METHODS: One hundred twenty consecutive patients with AF underwent MRI before ablation, 24 hours after ablation, and at 4-6 weeks. In all patients, simultaneous activation of pulmonary vein ablation catheter electrode pairs 1 and 5 was forbidden. While in 60 group 1 patients, a maximum of 4 electrode pairs could be activated at a time, and in 60 group 2 patients, ablation was limited to a maximum of 2 pairs. All patients were on uninterrupted phenprocoumon, with an attempted activated clotting time of >300 seconds during ablation.
RESULTS: Both patient groups were comparable. A total of 28 DW-positive lesions were detected in 24 of 120 patients (20%). Seventeen group 1 patients (28.3%) were positive for new asymptomatic DW cerebral lesions compared with 7 group 2 patients (11.7%) (P = .039). During MRI follow-up, 3 patients (2.5%) were diagnosed with a small T2-positive asymptomatic glial scar. Procedure time was longer in group 2 patients than in group 1 patients (159 ± 39 vs 121 ± 15; P < .001).
CONCLUSIONS: Limiting the number of simultaneously activated electrode pairs to 2 significantly reduces the rate of ACE in patients treated with a multielectrode duty-cycled phased radiofrequency catheter system for AF. This reduction corresponds with a significant prolongation of the total procedure time.
Copyright © 2013 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23567660     DOI: 10.1016/j.hrthm.2013.04.005

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  19 in total

1.  Neuropsychological impact of cerebral microemboli in ablation of atrial fibrillation.

Authors:  S Kochhäuser; H H Lohmann; M A Ritter; P Leitz; F Güner; S Zellerhoff; C Korsukewitz; D G Dechering; J Banken; N M Peters; L Eckardt; G Mönnig
Journal:  Clin Res Cardiol       Date:  2014-10-22       Impact factor: 5.460

Review 2.  Multielectrode Pulmonary Vein Ablation Catheter (PVAC(®)): current data on results and risks.

Authors:  Gerold Mönnig; Lars Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2014-12

Review 3.  The Impact of Advances in Atrial Fibrillation Ablation Devices on the Incidence and Prevention of Complications.

Authors:  Fehmi Keçe; Katja Zeppenfeld; Serge A Trines
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-08

4.  Silent cerebral events as a result of left atrial catheter ablation do not cause neuropsychological sequelae--a MRI-controlled multicenter study.

Authors:  Christian von Bary; Thomas Deneke; Thomas Arentz; Anja Schade; Heiko Lehrmann; Christoph Eissnert; Susanne Schwab-Malek; Sabine Fredersdorf; Ekrem Ücer; Dobri Baldaranov; Christina Wendl; Felix Schlachetzki
Journal:  J Interv Card Electrophysiol       Date:  2015-04-29       Impact factor: 1.900

5.  Clinical outcomes of AF patients treated with the first and second-generation of circular mapping and ablation catheter: insights from a real world multicenter experience.

Authors:  Giovanni Rovaris; Paolo De Filippo; Francesco Laurenzi; Gabriele Zanotto; Nicola Bottoni; Mattia Pozzi; Fabrizio Giofrè; Piergiuseppe De Girolamo; Emanuela Visentin; Elena Piazzi; Paola Ferrari
Journal:  J Interv Card Electrophysiol       Date:  2017-09-05       Impact factor: 1.900

Review 6.  Influence of cardioversion on asymptomatic cerebral lesions following atrial fibrillation ablation.

Authors:  Guijian Liu; Ruizhen Chen; Wenqing Zhu; Kuan Cheng; Ye Xu; Qingxing Chen; Junbo Ge
Journal:  J Interv Card Electrophysiol       Date:  2014-06-14       Impact factor: 1.900

7.  Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.

Authors:  David R Van Wagoner; Jonathan P Piccini; Christine M Albert; Mark E Anderson; Emelia J Benjamin; Bianca Brundel; Robert M Califf; Hugh Calkins; Peng-Sheng Chen; Nipavan Chiamvimonvat; Dawood Darbar; Lee L Eckhardt; Patrick T Ellinor; Derek V Exner; Richard I Fogel; Anne M Gillis; Jeff Healey; Stefan H Hohnloser; Hooman Kamel; David A Lathrop; Gregory Y H Lip; Reena Mehra; Sanjiv M Narayan; Jeffrey Olgin; Douglas Packer; Nicholas S Peters; Dan M Roden; Heather M Ross; Robert Sheldon; Xander H T Wehrens
Journal:  Heart Rhythm       Date:  2014-11-18       Impact factor: 6.343

8.  Catheter Ablation of Atrial Fibrillation: Advent of Second-Generation Technologies.

Authors:  Eric Buch; Kalyanam Shivkumar
Journal:  J Am Coll Cardiol       Date:  2015-09-22       Impact factor: 24.094

Review 9.  Phased RF Ablation: Results and Concerns.

Authors:  Alexandra Kiss; Gábor Sándorfi; Edina Nagy-Baló; Mihran Martirosyan; Zoltan Csanadi
Journal:  J Atr Fibrillation       Date:  2015-06-30

Review 10.  Silent Cerebral Events after Atrial Fibrillation Ablation - Overview and Current Data.

Authors:  Thomas Deneke; Karin Nentwich; Joachim Krug; Patrick Müller; Peter Hubert Grewe; Andreas Mügge; Anja Schade
Journal:  J Atr Fibrillation       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.